-
India’s Biocon plans IPO for biosimilars business by March 2026
31 Jan 2025 15:50 GMT
… (Reuters) – Indian biopharmaceutical firm Biocon is likely to list its … market share for them, Biocon Biologics CEO Shreehas Tambe told … about 40% in revenue to Biocon Biologics, followed by 35% … months.
The firm hopes to benefit from U.S. President Donald …
-
Budget 2025: HDFC Bank, Zomato to Biocon - Rahul Ghose of Hedged.in suggests 6 stocks to buy ahead of Union Budget
22 Jan 2025 11:17 GMT
… levels.
Many pharma stocks like Biocon, Lupin, Dr Reddy are in … . HDFC Bank in financials, and Biocon in healthcare stand out apart … . They are well-positioned to benefit from long-term sectoral tailwinds …
-
Stock Radar: Is Biocon losing momentum after hitting a fresh 52-week high in January 2025? Here’s what chart suggests
22 Jan 2025 00:04 GMT
… range on the weekly charts.
Biocon Ltd, in the pharma sector … stop loss below Rs 365.
Biocon Ltd, part of the pharma … 1-2 months, suggest experts.Biocon stock price got stuck in … credentials to enjoy all member benefits.
Sign in & Access ET …
-
Stock Radar: Biocon offers fresh buying opportunity; stock hits 52-week high in January
21 Jan 2025 04:45 GMT
… 3-4 weeks, suggested experts.
Biocon stock hit a 52-week … Pattern, indicating a bullish trend.
Biocon Ltd, a part of the … suggested experts.Tracking the momentum, Biocon stock price hit a fresh … credentials to enjoy all member benefits.
Sign in & Access ET …
-
Biocon shares near Sept 2024 high as HSBC upgrades stock to buy; here's target price
14 Jan 2025 10:04 GMT
… The foreign brokerage believes Biocon is well-positioned for operational … of biosimilars, we believe Biocon is improving its execution, … the plant, HSBC said.
Biocon's Bengaluru plant … for aspart, which could benefit Biocon as the exclusive biosimilar …
-
Stocks to buy today: HSBC upgrades Biocon; MOSL sees 20% rise in HCL Tech post Q3 results
14 Jan 2025 05:01 GMT
… 12 months.HSBC has upgraded Biocon, citing an operational turnaround driven … credentials to enjoy all member benefits
Log out of your current … credentials to enjoy all member benefits.
Sign in & Access ET …
-
Stock Radar: Biocon stock price breaks out from upper band of a Symmetrical Triangle; should you buy?
08 Jan 2025 23:41 GMT
Biocon Ltd's stock has … target of Rs 403-436.
Biocon Ltd has broken out of … averages, indicating a bullish trend.
Biocon Ltd, part of the pharma … credentials to enjoy all member benefits.
Sign in & Access ET …
-
Biosimilars Market Industry Trends and Global Forecasts to 2035, Featuring Amgen, BIOCAD, Biocon, Celltrion, Coherus BioSciences, Eli Lilly, Fresenius Kabi, Pfizer, Sandoz and Teva Pharmaceuticals - ResearchAndMarkets.com
10 Dec 2024 14:58 GMT
… Forecast and Opportunity Analysis
Key Benefits of Buying this Report
The … the Report include:
Amgen
BIOCAD
Biocon
Celltrion
Coherus BioSciences
Reddy… AND REST OF THE WORLD
Biocon
Dr. Reddy's Laboratories …
-
Why Mayuresh Joshi prefers Syngene to Biocon, Paradeep Phosphates to UPL
12 Nov 2024 02:44 GMT
… Marketsmith watch list compared to Biocon.
Any first thoughts on … context, these NBFCs might benefit from earnings as we go … the domestic cyclicals.
What about Biocon? The stock is doing … , small molecules perspective. For Biocon to a certain extent, numbers …
-
The US wants to cut its reliance on Chinese pharma. These Indian stocks could benefit.
07 Oct 2024 06:59 GMT
… are expected to reap the benefits of the act as the … at three companies expected to benefit from the US Biosecure Act … , Syngene International, a subsidiary of Biocon, has returned almost 193% to … new US regulations that could benefit India, there could be a …
About
© 1995-2025